Cancer therapy-related complications in the bowel and mesentery: an imaging perspective
- 8 June 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Abdominal Radiology
- Vol. 41 (10), 2031-2047
- https://doi.org/10.1007/s00261-016-0799-3
Abstract
Cancer therapy-induced complications in the bowel and mesentery are fairly common. It is important for clinicians to be aware of these complications and the agents most frequently implicated. Cancer therapy is rapidly evolving and often encompasses both classic cytotoxic drugs and newer molecular targeted agents. Drugs from both broad classes can have numerous adverse effects on the bowel and mesentery that can be detected on imaging. These adverse effects include ileus, various forms of enterocolitis, gastrointestinal perforation, pneumatosis intestinalis, secretory diarrhea, and sclerosing mesenteritis. These complications are diverse and range from relatively benign to life threatening. The management is also variable, but many of these conditions are easily controlled and reversed with supportive care and cessation of the particular cancer therapy. The objective of this pictorial essay is to demonstrate some of the more common cancer therapy-induced complications of the bowel and mesentery, with a focus on the radiographic findings.Keywords
This publication has 81 references indexed in Scilit:
- Neutropenic Enterocolitis, a Growing Concern in the Era of Widespread Use of Aggressive ChemotherapyClinical Infectious Diseases, 2012
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based RegimenJournal of Clinical Oncology, 2012
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- LethalClostridium difficileColitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the LiteratureObstetrics and Gynecology International, 2010
- Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2010
- Pneumatosis Intestinalis in the Adult: Benign to Life-Threatening CausesAmerican Journal of Roentgenology, 2007
- Risk of Bowel Perforation in Patients Receiving Interleukin-2 After Therapy With Anti-CTLA 4 Monoclonal AntibodyJournal of Immunotherapy, 2007
- Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4Journal of Clinical Oncology, 2006
- Pneumatosis IntestinalisAnnals of Surgery, 1990
- Radiologic manifestations of small-bowel toxicity due to floxuridine therapyAmerican Journal of Roentgenology, 1986